✦ LIBER ✦

Radio-sequence analysis of in Vivo multilabeled nonstructural protein ns86 of semliki forest virus

✍ Scribed by Nisse Kalkkinen; Matti Laaksonen; Hans Söderlund; Hans Jornvall

Book ID: 119010287
Publisher: Elsevier Science
Year: 1981
Tongue: English
Weight: 796 KB
Volume: 113
Category: Article
ISSN: 0042-6822
DOI: 10.1016/0042-6822(81)90147-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis and Processing of Semliki Fore

Synthesis and Processing of Semliki Forest Virus-Specific Nonstructural Proteins in vivo and in vitro

✍ Päivi LEHTOVAARA; Ismo ULMANEN; Leevi KÄÄRIÄINEN; Sirkka KERÄNEN; Lennart PHILIP 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 838 KB

Semliki Forest virus vectors with mutati

Semliki Forest virus vectors with mutations in the nonstructural protein 2 gene permit extended superinfection of neuronal and non-neuronal cells

✍ Markus U. Ehrengruber; Alan L. Goldin 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 712 KB

Sequence Analysis of Pns11, a Nonstructu

Sequence Analysis of Pns11, a Nonstructural Protein of Rice Gall Dwarf Virus, and its Expression and Detection in Infected Rice Plants and Vector Insects

✍ Yusuke Moriyasu; Koichi Ishikawa; Akira Kikuchi; Shigeo Imanishi; Shuichiro Tomi 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 81 KB

The Genomic Sequence of Defective Interf

The Genomic Sequence of Defective Interfering Semliki Forest Virus (SFV) Determines Its Ability to Be Replicated in Mouse Brain and to Protect against a Lethal SFV Infectionin Vivo

✍ Michael Thomson; Christine L. White; Nigel J. Dimmock 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 867 KB

Genotypic and phenotypic analysis of var

Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations

✍ Robert A. Fridell; Chunfu Wang; Jin-Hua Sun; Donald R. O'Boyle II; Peter Nower; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB 👁 1 views

The NS5A replication complex inhibitor, BMS-790052, inhibits hepatitis C virus (HCV) replication with picomolar potency in preclinical assays. This potency translated in vivo to a substantial antiviral effect in a single-ascending dose study and a 14-day multiple-ascending dose (MAD) monotherapy stu